BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 37844572)

  • 21. FDG PET/CT Findings of a Synovial Sarcoma in a Renal Transplant.
    Yang X; Wang W; Kan Y; Liu J; Yang J
    Clin Nucl Med; 2019 Mar; 44(3):259-261. PubMed ID: 30589671
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical utility of FDG PET/CT for primary and recurrent papillary renal cell carcinoma.
    Hou G; Zhao D; Jiang Y; Zhu Z; Huo L; Li F; Cheng W
    Cancer Imaging; 2021 Feb; 21(1):25. PubMed ID: 33632314
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 18F-FDG PET/CT and 99mTc-MIBI SPECT/CT Findings in a Patient With Eosinophilic Solid and Cystic Renal Cell Carcinoma.
    Tong Z; Shen Q; Sun H; Zhang J; Fan Y
    Clin Nucl Med; 2022 May; 47(5):464-466. PubMed ID: 35085167
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Solitary Central Nervous System Relapse of Posttransplant Lymphoproliferative Disorder on 18 F-FDG PET/CT.
    Feng L; Yang X; Lu X; Wang W; Yang J
    Clin Nucl Med; 2022 Nov; 47(11):1007-1009. PubMed ID: 35835131
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 68 Ga-FAPI-04 PET/CT and 18 F-FDG PET/CT in Metastatic Papillary Renal Cell Cancer.
    Civan C; Isik EG; Karadogan S; Sanli Y; Kuyumcu S
    Clin Nucl Med; 2023 May; 48(5):e223-e224. PubMed ID: 36754359
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of renal cell carcinoma histological subtype and fuhrman grade using
    Nakajima R; Nozaki S; Kondo T; Nagashima Y; Abe K; Sakai S
    Eur Radiol; 2017 Nov; 27(11):4866-4873. PubMed ID: 28523353
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pyrexia of unknown origin as clinical presentation of Renal Cell Carcinoma: Role of F18-FDG PET/CT.
    Asghar N; Hassan A
    J Pak Med Assoc; 2020 Feb; 70(2):371. PubMed ID: 32063640
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Isolated Humeral Metastasis as the Initial Presentation of Renal Cell Carcinoma Revealed by 18 F-FDG PET/CT.
    Hou G; Zhang W; Zheng R
    Clin Nucl Med; 2023 Jun; 48(6):538-539. PubMed ID: 36976679
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical utility of
    Nakamoto Y; Ishimori T; Shimizu Y; Sano K; Togashi K
    Eur J Nucl Med Mol Imaging; 2019 Jul; 46(7):1524-1530. PubMed ID: 30847538
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Contrast-enhanced ultrasound findings of post-transplant lymphoproliferative disorder in a transplanted kidney: A case report and literature review.
    Lampe A; Duddalwar VA; Djaladat H; Aron M; Gulati M
    J Radiol Case Rep; 2015 Oct; 9(10):26-34. PubMed ID: 26629291
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increased Genioglossus Muscle FDG Activity Due to Using Pacifier.
    Tong C; Zhuang H
    Clin Nucl Med; 2022 Jul; 47(7):655-657. PubMed ID: 35195586
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rapidly Progressing Renal Cell Cancer of the Left Native Kidney in a Renal Transplant Recipient With Unusual Sites of Metastasis Demonstrated in Serial 18F-FDG PET/CT.
    Rangan B K K; Ora M; Suraj AS; Parashar A; Gambhir S
    Clin Nucl Med; 2019 Oct; 44(10):e574-e576. PubMed ID: 31348078
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The accuracy of positron emission tomography in the detection of posttransplant lymphoproliferative disorder.
    Dierickx D; Tousseyn T; Requilé A; Verscuren R; Sagaert X; Morscio J; Wlodarska I; Herreman A; Kuypers D; Van Cleemput J; Nevens F; Dupont L; Uyttebroeck A; Pirenne J; De Wolf-Peeters C; Verhoef G; Brepoels L; Gheysens O
    Haematologica; 2013 May; 98(5):771-5. PubMed ID: 23065524
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Usefulness of F-18 FDG-PET in a long-term hemodialysis patient with renal cell carcinoma and pheochromocytoma.
    Ozawa N; Okamura T; Koyama K; Hamazawa Y; Senzaki H; Tanabe S; Ikemoto S; Inoue Y
    Ann Nucl Med; 2007 Jun; 21(4):239-43. PubMed ID: 17581724
    [TBL] [Abstract][Full Text] [Related]  

  • 35. FDG PET/CT in a Case With Cellular Schwannoma of the Kidney.
    Yu Z; Zhang J; Dong A; Zhu Y
    Clin Nucl Med; 2022 Nov; 47(11):996-997. PubMed ID: 35619199
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Malignant Peripheral Nerve Sheath Tumor Arising From Transplanted Kidney Assessed by 18F-FDG PET/CT.
    Feng H; Tu N; Bu L
    Clin Nucl Med; 2020 Nov; 45(11):905-907. PubMed ID: 32969901
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Von Hippel-Lindau Disease-Associated Microcystic Adenoma of the Ethmoid Sinus Mimicking Metastatic Clear Cell Renal Cell Carcinoma.
    Tsukamoto S; Koyasu S; Sugimoto A; Matsunaga M; Nakamoto Y
    Clin Nucl Med; 2023 Feb; 48(2):194-196. PubMed ID: 36179325
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hodgkin lymphoma post-transplant lymphoproliferative disorder following pediatric renal transplant: serial imaging with F-18 FDG PET/CT.
    Makis W; Lisbona R; Derbekyan V
    Clin Nucl Med; 2010 Sep; 35(9):704-5. PubMed ID: 20706047
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gallbladder Metastasis From Renal Cell Carcinoma Revealed With 18 F-FDG PET/CT.
    Baloğlu MC; Yahşi S; Erol Fenercioğlu Ö; Çermik TF; Ergül N
    Clin Nucl Med; 2022 Sep; 47(9):e587-e588. PubMed ID: 35452011
    [TBL] [Abstract][Full Text] [Related]  

  • 40. FDG PET/CT of Chromophobe Renal Cell Carcinoma With Sarcomatoid Differentiation.
    Lee CH; Kesari V; Legesse T; Chen W
    Clin Nucl Med; 2018 May; 43(5):367-369. PubMed ID: 29485439
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.